Specialty Natural Products Public Company (SNPS) Fair Value & Analysis
Consumer Defensive · TH · Market cap 1.8B THB
Fair value as of: Jun 24, 2026
From 26 valuation models · updated 5 days ago
Fair value updated Jun 24, 2026 — revised from 5.03 THB to 5.22 THB (+3.8%) since Jun 23, 2026. Share price +0.9% over the past month.
Price vs Fair Value (12 months)
12‑month range 4.09 THB – 5.05 THB · fair‑value band 3.42 THB – 6.91 THB · the 4.56 THB price screens below the 5.22 THB fair value. As of Jun 24, 2026.
✦ Which stocks are undervalued right now? Check free Discover now →Analysis
Specialty Natural Products Public Company (SNPS) currently trades at 4.56 THB, while our model-based Fair Value estimate is 5.22 THB — implying the stock looks roughly 14.5% undervalued today. We read business quality at 91/100 (high quality), in the Consumer Defensive sector. Bull case: trading below our estimate, it may offer upside if the fundamentals hold. Bear case: a low price can be a value trap when quality is weak or the data is thin (evidence: high) — always confirm before acting.
Over the trailing twelve months, Specialty Natural Products Public Company generated revenue of 572M THB at a net margin of 20.8%. Revenue declined 0.1% year over year. It earns a return on equity of 12.4%. The balance sheet holds a net cash position of 427M THB. Fundamentals as of Jun 24, 2026
Key figures & financial health
More key figures
Figures from reported company fundamentals (EODHD) · as of Jun 24, 2026. TTM = trailing twelve months.
About the company
Specialty Natural Products Public Company Limited manufactures and distributes herbal extracts, cosmetics, beverages, health supplements, and traditional medicines in Thailand and internationally. The company also offers extracts for nutraceuticals and cosmeceuticals for use in weight and immune control, blood pressure and sugar, antiaging, hair nourishment, whitening, wound healing, UV protection, rejuvenation for men, slimming, cosmetic mosturerizing, antibacterial, antioxidant, nutrition, and anti-inflammatory; natural additives, such as eucalyptus, ginger, jojoba, kaffir lime, lavender, lemon, lemongrass, lime, orange, peppermint, plai, turmeric, rice bran, and tea tree oil; and other additives, including amino cleansers, concentrate shampoo, SNP-alpha arbutin, Argirena, clear soap, cremaflow, emulbase, ICM, nonawax, polyol complex, solubilisant, standard EB, surfactant base1, sunsil tin50, tiospere 50BG, TOG, supersil E, and standard EB. In addition, it provides herbal active p…
Revenue & earnings trend
FY2021 – FY2025 · reported fiscal years
Specialty Natural Products Public Company reported revenue of 554M THB in FY2025 versus 708M THB in FY2021, a compound −6.0%/yr. Reported net income was 112M THB in FY2025, compounding −9.9%/yr from FY2021.
Open the full interactive analysis →
Similar stocks
6 more Household & Personal Products stocks, each showing price versus our Fair Value estimate (as of Jun 24, 2026).
| Stock | Price | Fair Value | vs Fair Value |
|---|---|---|---|
| The Procter & Gamble Company PG | 2,590 MXN | 1,732 MXN | -33% |
| L'Oréal S.A LRLCF | $450.56 | $209.17 | -54% |
| Unilever PLC UNLYF | $59.34 | $46.11 | -22% |
| Colgate-Palmolive Company CPA | €77.58 | €35.72 | -54% |
| Hindustan Unilever Limited HINDUNILVR | ₹2,122 | ₹677.55 | -68% |
| Reckitt Benckiser Group RBGLY | $12.32 | $17.37 | +41% |
Explore undervalued stocks
More undervalued Consumer Defensive stocks →
Frequently asked questions
Is Specialty Natural Products Public Company (SNPS) undervalued?
What is the fair value of SNPS?
What is the quality score of SNPS?
What is the revenue of Specialty Natural Products Public Company (SNPS)?
What is the net profit margin of SNPS?
Does Specialty Natural Products Public Company pay a dividend?
How we calculate Fair Value
Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.
Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.